THE EPIVAX THERAPEUTICS TEAM

Management Committee

Headshot.jpg

DAN ADAMS, JD

Chairman, EpiVax Therapeutics

Daniel Adams is the Executive Chairman and Co‐Founder of NextWaveBio, a next‐generation biotechnology enterprise developing safer, more affordable pharmaceuticals. Previously, Dan founded and managed several biotechnology companies including Biogen that achieved a combined value of well in excess of $60 billion.

ADG - Headshot.jpg

ANNE (ANNIE) DE GROOT, MD

Co-Founder, CEO & CSO @ EpiVax

Annie is internationally known for her research on the human immune system’s response to vaccines and therapeutics. She is a physician, immunologist, and co-founder and CEO/CSO of the immunoinformatics company, EpiVax.

Bill.PNG

WILLIAM MARTIN, BA

Co-Founder, COO & CIO @ EpiVax

Bill is the principal architect and developer of the current EpiMatrix System. Over the past 19 years, Mr. Martin has revised and expanded the EpiMatrix toolkit building on the research initially performed in Dr. De Groot's Brown University laboratory.

 

Senior Technical Team

gary-d-steinberg-square headshot.jpg

GARY STEINBERG, MD

Chief Medical Officer

EO_Michael Princiotta Headshot.jpg

MICHAEL PRINCIOTTA, PHD

Chief Scientific Officer

NicoleHeadshot_edited.png

NICOLE RUGGIERO

Chief Operating Officer

M7_06364.jpg

GUILHEM RICHARD, PHD

Lead Computational Immunologist

 

Board of Directors

Headshot.jpg

DAN ADAMS, JD

Chairman, EpiVax Therapeutics

ADG - Headshot.jpg

ANNE (ANNIE) DE GROOT, MD

Co-Founder, CEO & CSO @ EpiVax

Bill_edited.jpg

WILLIAM MARTIN, BA

Co-Founder, COO & CIO @ EpiVax

RL headshot.png

RICHARD LIPKIN, MBA

Managing Director @ Easton Capital